Bionano Genomics, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported revenue was USD 10.72 million compared to USD 8.22 million a year ago. Net loss was USD 43.89 million compared to USD 38.68 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.844 USD | +1.07% | -5.13% | -55.34% |
May. 28 | Bionano Genomics Raises $18 Million From Private Debentures Placement | MT |
May. 24 | Bionano Genomics, Inc. announced that it has received $18 million in funding | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-55.34% | 58.33M | |
+10.23% | 189B | |
+25.36% | 150B | |
+33.13% | 113B | |
+2.36% | 65.05B | |
+14.98% | 52.83B | |
+1.91% | 49.39B | |
-6.09% | 38.1B | |
-0.43% | 35.14B | |
+23.46% | 31.2B |
- Stock Market
- Equities
- BNGO Stock
- News Bionano Genomics, Inc.
- Bionano Genomics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023